GlaxoSmithKline fined $3 billion after bribing doctors to increase drugs sales | WHAT REALLY HAPPENED

GlaxoSmithKline fined $3 billion after bribing doctors to increase drugs sales

The pharmaceutical group GlaxoSmithKline has been fined $3bn (£1.9bn) after admitting bribing doctors and encouraging the prescription of unsuitable antidepressants to children. Glaxo is also expected to admit failing to report safety problems with the diabetes drug Avandia in a district court in Boston on Thursday.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA